Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02727452
Other study ID # E 9/15
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2016
Est. completion date December 2019

Study information

Verified date February 2022
Source Johann Wolfgang Goethe University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The randomised study analyzes the effects of immediate bonding (skin-to-skin contact) on different psychobiological and somatic outcomes of mother and child. The investigators compare 3 bonding conditions. Cortisol and Oxytocin are also measured during the bonding process.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 2019
Est. primary completion date December 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Mothers with elective Caesarean Section and their partners Exclusion Criteria: - premature birth - severe diseases - drug abuse

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Skin-to-skin contact


Locations

Country Name City State
Germany University Hospital Frankfurt-Dept.Obstetrics and Perinatal Medicine Frankfurt Hessen

Sponsors (1)

Lead Sponsor Collaborator
Johann Wolfgang Goethe University Hospital

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Cortisol Level Cortisol is assessed as a stress parameter by Saliva. It will be tested in the mother and child to measure the effect of immediate bonding with the mother compared to the other 2 conditions on the stress level 30 and 60 minutes after bonding
Secondary Depression assessed by EPDS 1-3 days and 6 weeks after childbirth
Secondary Mother-child-bonding assessed by PBQ 1-3 days and 6 weeks after childbirth
Secondary Child's heart ratio 30 and 60 minutes after birth
Secondary Child's oxygen saturation 30 and 60 minutes after birth
Secondary Child's temperature 30 and 60 minutes after birth
Secondary Oxytocin Saliva measurement 30 and 60 minutes after birth
See also
  Status Clinical Trial Phase
Completed NCT03176459 - Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections Phase 4
Completed NCT03834415 - Lactobacillus Reuteri DSM17938 in C-Section Infants N/A